Actuate Therapeutics Inc.
ACTU
Get informed when a big investor buys or sells
+ FollowMarket Cap$48.33M
Close$
$0.61
66.7% downside
Current Fair Value
66.7% downsideOvervalued by 66.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $48.33 Million |
|---|---|
| Enterprise Value | $40.20 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.06 |
| Beta | 0.93 |
| Outstanding Shares | 23,537,134 |
Return
| Return on Equity | -569.09% |
|---|---|
| Return on Assets | -241.68% |
| Return on Invested Capital | -520.61% |
Valuation & Multiples
| P/E Ratio | -2.21 |
|---|---|
| PEG | 20.17 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.84 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 59.62%▼ 1.66% |
|---|---|
| Total Invested | $37.97M▼ 52.68% |
| Investors Holding | 61▲ 17.00% |
ESG Score
No data